SCHEMBL26066853

SCHEMBL26066853

COc1ccc(C(NCCCC[C@H](NC(=O)COCC(=O)NCCOCCOCCN)C(=O)Nc2ccc(CO)cc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 8/20 0.39
▸ HDAC1 Q13547 6/20 0.39
▸ HDAC2 Q92769 5/20 0.39
▸ HDAC7 Q8WUI4 5/20 0.39
▸ HDAC3 O15379 4/20 0.39
▸ HDAC4 P56524 4/20 0.39
▸ HDAC10 Q969S8 4/20 0.39
▸ HDAC11 Q96DB2 4/20 0.39
▸ HDAC6 Q9UBN7 4/20 0.39
▸ HDAC9 Q9UKV0 4/20 0.39
▸ HDAC5 Q9UQL6 4/20 0.39
▸ SIRT1 Q96EB6 2/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.36
▸ NPY1R P25929 3/20 0.36
▸ NPY4R P50391 1/20 0.36
▸ CCKAR P32238 1/20 0.35
▸ CCKBR P32239 1/20 0.35
▸ EPOR P19235 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26066857 1.00 HDAC8 (0.39) HDAC8HDAC1HDAC2HDAC7HDAC3
SCHEMBL25218460 0.92 HDAC8 (0.36) HDAC8HDAC1HDAC2HDAC7HDAC3
SCHEMBL25242024 0.90 FOLH1 (0.37) HDAC8HDAC1HDAC2HDAC7HDAC3
SCHEMBL25242026 0.90 FOLH1 (0.37) HDAC8HDAC1HDAC2HDAC7HDAC3
SCHEMBL19732156 0.89 FOLH1 (0.37) HDAC8HDAC1HDAC2HDAC7HDAC3
SCHEMBL26067020 0.87 NPY1R (0.33) HDAC1HDAC7NPY1RNPY4RCCKAR
SCHEMBL27190126 0.87 HDAC8 (0.34) HDAC8HDAC1HDAC2HDAC7HDAC3
SCHEMBL27189832 0.87 HDAC8 (0.34) HDAC8HDAC1HDAC2HDAC7HDAC3
SCHEMBL26066952 0.84 ALDH1A1 (0.39) HDAC1HDAC7EPOR
SCHEMBL31681443 0.84 SIRT1 (0.37) SIRT1SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230270867-A1 CONJUGATE IN WHICH FL118 DRUG IS LINKED TO ACID-SENSITIVE LINKER, AND IMMUNOCONJUGATE USING SAME PINOTBIO, INC. (KR) 2023-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230270867-A1 CONJUGATE IN WHICH FL118 DRUG IS LINKED TO ACID-SENSITIVE LINKER, AND IMMUNOCONJUGATE USING SAME SLC46A1, SLC47A1, FOLR1 HDAC8 1121/4885HDAC1 3656/4885HDAC2 4225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback